Objective: Autogenous vein is the conduit of choice in patients presenting for infrainguinal arterial reconstruction. Venous conduit may be limited because of inadequacy or prior utilization. Our group and others use prosthetics to maximize limb salvage with moderate results. However, in cases where patients present with an isolated popliteal segment that may extend below the knee, we have performed prosthetic bypasses to this above-knee segment and then used a venous reconstruction from the native arterial circulation to a more distal outflow tract. In this report, we will analyze our results using this type of reconstruction in patients who present for limb salvage with no all-autogenous option. Over the past several decades, limb salvage has improved markedly with use of infrainguinal arterial reconstruction.
Over the past several decades, limb salvage has improved markedly with use of infrainguinal arterial reconstruction. 1 Our group and others feel that autogenous vein is the conduit of choice in patients who present with limb-threatening ischemia. However, the presence of ipsilateral greater saphenous vein has decreased in recent years. 2 This may be the result of both inadequacy or prior utilization. Autogenous composite (or spliced vein) bypass also provides reasonable patency rates and allows excellent limb salvage. 3 When a spliced vein option is not available, we have used prosthetic conduit to an isolated popliteal artery segment as described by Mannick et al. 4 By using adjuncts such as a distal arteriovenous fistula (DAVF) or a distal vein cuff (DVC), we have had acceptable results with prosthetic bypasses to the below-knee popliteal or tibial vessels. 5 However, in cases where patients present with an isolated popliteal segment that may extend below the knee, we have performed prosthetic bypasses to this above-knee segment and then used a venous reconstruction from the native arterial circulation to a more distal outflow tract. This technique is not a new concept. It was originally described by DeLaurentis and Friedmann 6 in five patients nearly 30 years ago. Recent reports have detailed series that do not differentiate whether the distal vein bypass originates from the prosthetic graft hood or the native artery. [7] [8] [9] [10] In this report, we analyze our results using this type of "composite sequential" reconstruction in patients who present for limb salvage with no all-autogenous option and require use of the native popliteal artery segment for adequate revascularization. We also compare outcomes with this technique to prosthetic bypass taken below the knee with either a DVC or a DAVF as an adjunct as well as to composite autogenous (or spliced vein) reconstructions.
PATIENTS AND METHODS
From 1992 to 2000, all patients presenting with lower extremity ischemia to Albany Medical Center were entered prospectively into a vascular surgery registry. This includes 4421 infrainguinal arterial reconstructions. When limb salvage was the indication for surgery (rest pain or tissue loss), we identified 3744 patients. Of these, spliced vein was used in 536 cases. We performed a retrospective review of the remaining 3208 patients finding all whose indication for surgery was limb salvage, whose superficial femoral artery was occluded leaving an isolated popliteal artery, and who had inadequate vein for a continuous bypass. This group of patients was called the composite sequential group. These patients all received an 8-mm polytetrafluoroethylene (PTFE) graft without an adjunct such as a DVC or a DAVF to the above-knee popliteal artery. The vein bypass originated from a native artery distal to prosthetic bypass. Both bypasses were done at the same setting in all cases. No anticoagulation was used postoperatively unless required for other medical reasons. The specific indication, demographics, type of composite reconstruction, and outcome were determined. Patency and limb salvage rates were calculated by life table methods. Data were then obtained from all infrageniculate prosthetic (6-mm PTFE) bypasses accompanied by either a DVC or an DAVF as well as from all composite autogenous (spliced vein) bypasses done for arterial limb ischemia. All patients with a prosthetic bypass having a DAVF or DVC were maintained on warfarin for anticoagulation. Comparisons were performed using log rank analysis between these other three groups and the composite sequential bypasses. Statistical significance was assumed for P Ͻ .05. Early in this series, we preferentially used prosthetic bypass with a DVC or DAVF in the setting of limb-threatening ischemia and no all-autogenous option. Over the past 5 years, and especially over the last 2 years, we have relied more on a composite sequential bypass when possible for a theoretical advantage over pure prosthetic. That is, we perceived that the autogenous portion might improve limb salvage and patency because it was below the knee and the prosthetic was not.
RESULTS
During this 9-year review, 27 patients were identified who met the inclusion criteria. The mean age was 71 years (range, 51-87 years). Sixteen patients (59%) were men, 16 (59%) had diabetes, and 4 (15%) were active smokers. As far as indication for the procedure, 18 (67%) had a nonhealing ulcer, 7 (26%) had ischemic gangrene, and 2 (7%) had ischemic rest pain. For 26 of 27 patients, prior procedures had failed. The inflow and outflow arteries are detailed in Table I . The proximal prosthetic bypasses originated most often from the common femoral artery (n ϭ 21, 78%). Four (15%) originated from the proximal superficial femoral artery, and 2 (7%) from a prosthetic inflow graft in the groin. With regard to distal vein bypasses, the majority originated from the below-knee popliteal artery (n ϭ 18, 67%), thus utilizing the native vessel as a conduit crossing the knee joint. Eight of these grafts began in the popliteal artery above the knee but were at least 5-cm distal to the prosthetic bypass. One vein graft originated from the proximal peroneal artery. All prosthetic grafts ended without a DVC or a DAVF at the above-knee popliteal artery. The vein grafts were disbursed evenly among the various tibial vessels. Three vein grafts were sewn to the dorsalis pedis artery. All PTFE bypasses were 8 mm in diameter and 25 of 27 (93%) vein conduits were harvested from the arm, whereas 2 of 27 were lesser saphenous vein.
One patient died during the 30 days postoperatively, giving a mortality rate of 3.7%. Two vein graft occlusions occurred in the perioperative period, one at 20 days and the other at 40 days after surgery. The prosthetic grafts remained patent and the distal vein was not revised. Neither of these occlusions were associated with limb loss. One patient had hemodynamic failure of the bypass, which resulted in limb loss at 60 days post surgery. One patient had a wound infection, which required reoperation for débridement, and one patient had reoperation for bleeding. In long-term follow-up, one prosthetic graft occluded at 20 months with a patent vein graft. There was no further intervention because the patient remained asymptomatic. The mean Ϯ standard deviation time to follow-up was 12 Ϯ 4 months (range, 1-79 months). The short follow-up may be secondary to the fact that most of the composite sequential bypasses were done later in this series. Table II demonstrates primary patency,Table III secondary patency, Table IV limb salvage, and Table V survival in these 27 patients. At 1 year post procedure, there were no revisions such that primary and secondary patencies were both 91%. To determine whether the use of prosthetic conduit with a DVC or a DAVF was a better option than a composite sequential procedure, we used the data from a report already published by our group that compared these two PTFE conduits. 5 During this period, 47 bypasses were created with prosthetic and a DAVF, whereas 59 were done with prosthetic and a DVC. In total, these three types of bypasses encompassed only 4% of all lower extremity limbsalvage procedures at our institution. The composite sequential option was available in 20% of these patients who lacked adequate venous conduit. In our series, prosthetic bypass using a DVC in the setting of limb-threatening ischemia had a 1-year primary patency of 52% and a limbsalvage rate of 92%. These results did not differ significantly from those of the composite sequential option. When a prosthetic bypass was used with a DAVF placed distally, again in the setting of limb-threatening ischemia, 1-year primary patency was 73% with a limb-salvage rate of 84%. Again, these results did not differ significantly from those of the composite sequential series.
We further compared the data to our 536 composite autogenous (or spliced vein) bypasses done in the same period for patency, salvage, and survival. No significant differences were identified here as well (unpublished data, SPR).
DISCUSSION
Optimal management of infrainguinal occlusive disease is dependent upon the presence of ipsilateral greater saphenous vein. Use of this vein in an in situ or excised conıgu-ration has regularly demonstrated primary patency rates near 70% at 5 years. 1, [11] [12] [13] Unfortunately, the prior use of 14 demonstrated that use of the superficial femoral artery and popliteal artery for inflow may provide excellent results for infrainguinal reconstruction, decreasing the length of vein required. However, in patients with significant superficial femoral artery disease it may not be possible to use this distal inflow source. In comparison, our group and others have reported acceptable results with spliced vein reconstruction for limb-threatening ischemia. 3 Unfortunately, this procedure may require multiple surgical fields with a consequent increase in morbidity. 15 In some instances, lack of suitable autogenous conduit may make this option impossible. It is in this group that we have turned to a prosthetic conduit. However, the long-term patency of this reconstruction is somewhat poor. Veith et al, 16 in a multicenter trial evaluating obligatory prosthetic femorotibial bypass, reported a 3-year primary patency of 18%. This can be improved with a DAVF and anticoagulation. Ascer et al 17 found 3-year patency with PTFE conduits to be 62% in this setting. In selected patients, we employ PTFE bypass to an above-knee isolated popliteal segment. However, in patients with significant infrageniculate arterial occlusive disease presenting with limb-threatening ischemia, a bypass to an isolated popliteal segment may not be adequate for tissue healing. This leaves the surgeon with numerous secondary options when faced with no single autogenous resource. Dardik et al 18 have demonstrated 1-and 4-year patencies using umbilical vein with distal arteriovenous fistulas to a crural vessel of 40% and 25%, respectively. Alternatively, one can perform a composite sequential bypass. This is not a new concept. Verta 19 demonstrated a tibial reconstruction using a composite sequential technique and had patencies of 81% at 2 years and 72% at 4 years. Bastounis et al 20 also demonstrated that composite grafts of PTFE and saphenous vein were significantly superior to PTFE grafts alone for infrageniculate reconstruction and limb salvage. McCarthy et al 7 performed 67 composite sequential reconstructions with limb salvage of 84% at 2 years and 70% at 4 years. Their primary patencies at 1, 2, and 3 years were 72%, 64%, and 48%, respectively. These series all relied on obtaining the distal vein bypass from the prosthetic graft and not a distal native artery.
In hope of finding reconstruction options that would theoretically be advantageous, we have chosen a type of composite sequential reconstruction that uses a prosthetic (PTFE) above the knee to an isolated popliteal segment in combination with a vein bypass from a more distal arterial segment. Conceptually, we believed that using the native popliteal or tibial artery as the inflow source for the distal portion of this reconstruction might allow for continued patency even in the face of inflow compromise. This would theoretically maximize the flow through the prosthetic conduit while optimizing pulsatile blood flow to the ischemic area. Although the follow-up in this series is short, the early results are promising. In addition, this type of reconstruction may have patency and limb salvage comparable to and possibly better than those of prosthetic reconstructions to tibial vessels, and without the need for systemic anticoagulation. However, there was no difference in overall survival, suggesting that anticoagulation long-term did not affect mortality in these patients. As compared with bypass to an isolated popliteal segment, the composite sequential technique, in our opinion, is a way of achieving maximal improvement of tissue perfusion. This said, we would bypass directly to an isolated popliteal artery segment if no vein were available for a distal reconstruction.
In conclusion, infrageniculate arterial reconstruction with use of an isolated popliteal segment for composite sequential reconstruction is an acceptable option in patients presenting for limb-salvage reconstruction in conjunction with limited venous conduit. This type of reconstruction maximizes arterial flow to the affected tissue bed and is an option to prosthetic infrageniculate reconstruction with or without adjunct.
